Susan B Slemenda

Title: Susan B. Slemenda: Innovator in Viral Detection

Introduction

Susan B. Slemenda is a notable inventor based in Decatur, GA (US). She has made significant contributions to the field of virology, particularly in the detection of human adenoviruses. Her work has implications for diagnostic assays and vaccine development.

Latest Patents

Susan B. Slemenda holds a patent for the "Detection of human adenovirus." This invention relates to the DNA and proteins of human adenovirus Type 41 and their use in detecting the virus. Specifically, it involves the isolation of a 41.4 kd short fiber protein and a 60.6 kd long fiber protein of adenovirus type 41 (Ad41). The invention also includes proteins derived from the Ad41 E3 region, providing virus-derived antigens and active derivatives useful in developing diagnostic assays, DNA probes, and vaccines for the virus and related viruses.

Career Highlights

Slemenda's career is marked by her innovative research and development efforts. She works at Research Corporation Technologies, Inc., where she continues to advance her work in viral detection. Her patent has opened new avenues for understanding and combating human adenoviruses.

Collaborations

Some of her notable coworkers include Norman J. Pieniazek and Danuta Pieniazek. Their collaborative efforts have contributed to the success of her research and the development of her patented technologies.

Conclusion

Susan B. Slemenda's contributions to the field of virology through her patent on human adenovirus detection highlight her role as an innovator in medical research. Her work continues to impact the development of diagnostic tools and vaccines, showcasing the importance of innovation in healthcare.